Log in
Enquire now
InventisBio Inc

InventisBio Inc

InventisBio Inc is an oncology & Metabolic Diseases founded in 2013.

OverviewStructured DataIssuesContributors
Is a
Organization
Organization
Company
Company
Company Operating Status
Active
Country
China
China
0
Crunchbase URL
crunchbase.com/organiz...tisbio-2
Email Address
ir@inventisbio.com
0
Founded Date
2013
Full Address
Ltd. No. 63, Lane 1000, Zhangheng Road, Pudong New Area, Shanghai
0
Headquarters
Shanghai
Shanghai
0
Industry
Biopharmaceutical
Biopharmaceutical
Biomedical engineering
Biomedical engineering
Engineering
Engineering
Cancer
Cancer
Biotechnology
Biotechnology
Biology
Biology
Technology
Technology
Investors
Dyee Capital
Dyee Capital
‌
Pudong Innotek
Janchor Partners
Janchor Partners
‌
CMBI
Advantech Capital
Advantech Capital
CMB International Capital Corporation
CMB International Capital Corporation
QiMing Venture Partners
QiMing Venture Partners
Matrix Partners China
Matrix Partners China
OrbiMed
OrbiMed
E Fund Management (Hong Kong) Co., Limited
E Fund Management (Hong Kong) Co., Limited
•••
Latest Funding Round Date
September 2020
Latest Funding Type
Series D
Series D
LinkedIn URL
@company/%E7%9B%8A%E6%96%B9%E7%94%9F%E7%89%A9-inventisbio
Location
Shanghai
Shanghai
0
Phone Number
+862150778527
0
Pitchbook URL
pitchbook.com/profiles...181631-08
Total Funding Amount (USD)
236,000,000
Official Website
inventisbio.com/en/index.html
inventisbio.com

Find more companies like InventisBio Inc

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.